Working… Menu

Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01146652
Recruitment Status : Completed
First Posted : June 17, 2010
Last Update Posted : January 26, 2021
Regeneron Pharmaceuticals
Information provided by (Responsible Party):